Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): an open-label, randomised, phase 2 study

Alwin Krämer*, Tilmann Bochtler, Chantal Pauli, Kai Keen Shiu, Natalie Cook, Juliana Janoski de Menezes, Roberto A. Pazo-Cid, Ferran Losa, Debbie GJ Robbrecht, Jiří Tomášek, Cagatay Arslan, Mustafa Özgüroğlu, Michael Stahl, Frédéric Bigot, Sun Young Kim, Yoichi Naito, Antoine Italiano, Nasséra Chalabi, Gonzalo Durán-Pacheco, Chantal MichaudJeremy Scarato, Marlene Thomas, Jeffrey S. Ross, Holger Moch, Linda Mileshkin

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

5 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): an open-label, randomised, phase 2 study'. Together they form a unique fingerprint.

Medicine and Dentistry